Pharmaceutical protein production by transgenic chickens: several viewpoints towards the next stage

Key Points

• Pharmaceutical protein production can be enhanced in transgenic chickens, providing a novel platform.
• Compared to traditional methods, this approach may offer significant benefits in yield and scalability.
• Analysis of genetic modification techniques reveals their potential to create biopharmaceuticals more effectively.
• The implications of this technology point to improved access to essential medicines, impacting global health.